{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Marcus%20Research%20Laboratory%2C%20Inc.","name":"Marcus Research Laboratory, Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-03T23:51:09.914Z"},"count":1,"matches":[{"id":"e328fa47b66871f9","posted_date":"2021-10-19","letter_issue_date":"2021-09-30","company_name":"Marcus Research Laboratory, Inc.","issuing_office":"Division of Pharmaceutical Quality Operations III","subject":"CGMP/Active Pharmaceutical Ingredient (API)/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/e328fa47b66871f9"}]}